ARTICLE | Clinical News
BC-819: Pilot trial data
October 12, 2015 7:00 AM UTC
A pilot trial in 38 intermediate- and high-risk bladder cancer patients showed that an alternating treatment regimen with BC-819 followed by bacillus Calmette-Guerin (BCG) once or twice weekly was saf...